title: Prevention of muscle disuse atrophy by low-frequency electrical stimulation in rats.
abstract: When muscles lose neural drive, they atrophy rapidly. Neuromuscular electrical stimulation (NMS) has been used in attempts to prevent or reverse the atrophy, but optimal stimulation programs and parameters are not well defined. In this study, we investigated the effects of four different stimulation patterns on disuse atrophy produced in the tibialis anterior, lateral gastrocnemius, and soleus muscles of rats paralyzed with tetrodotoxin for seven days. Stimulation paradigms differed from one another by their stimulation frequency (2 or 10 pulses/s) and by their stimulation period (2 or 10 h a day). Results showed that stimulation with 2 pulses/s, paradigms were more effective at preventing disuse muscle atrophy than higher-frequency stimulation. The most marked difference was in the slow soleus muscle, which had only 10% mean atrophy when stimulated at 2 pulses/s for 10 h, compared to 26% atrophy when stimulated at 10 pulses/s for either 2 or 10 h and 32% atrophy in unstimulated, paralyzed controls. The level of atrophic change was not correlated with the levels of serum creatine kinase, used as an index of muscle damage. Results suggest that remediation of disuse atrophy may be accomplished using unphysiologically low rates of motor-unit activation despite the relatively low force produced by such unfused contractions. This may have significant implications for the design of therapies for muscle paralysis consequent to upper-motoneuron lesions.
mesh_terms: D000222:Adaptation, Physiological; D019412:Anatomy, Cross-Sectional; D000818:Animals; D000843:Ankle Joint / Q000473:pathology / Q000503:physiopathology; D004599:Electric Stimulation Therapy / Q000295:instrumentation / Q000379:methods*; D005260:Female; D009119:Muscle Contraction; D018485:Muscle Fibers, Skeletal / Q000378:metabolism / Q000473:pathology*; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D020966:Muscular Disorders, Atrophic / Q000097:blood / Q000473:pathology* / Q000503:physiopathology* / Q000517:prevention & control*; D009929:Organ Size; D010725:Phosphocreatine / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley; D013779:Tetrodotoxin; D016896:Treatment Outcome
chemical_list: D010725:Phosphocreatine; D013779:Tetrodotoxin